Clinical Trials in Detroit

Showing 9741-9760 of 16,931 trials

A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies

NCT02937675

This clinical trial is a Phase 1-2, open-label, sequential-group, dose-escalation and cohort-expansion study evaluating the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of Tomivosertib (eFT-508). The study will evaluate oral daily administration of Tomivosertib (eFT-508). Treatment and study subject evaluation will be performed in 21-day cycles.

Lymphoma

Effector Therapeutics28 participantsStarted Feb 2017

Los Angeles, California, United States • Sarasota, Florida, United States • Detroit, Michigan, United States +7 more locations

COMPLETEDNA6.7 miles

Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization

NCT02961894

To evaluate the safety and effectiveness of the Revolution™ Peripheral Atherectomy System in the treatment of infrainguinal lower extremity peripheral arterial occlusive disease. This Atherectomy system will be used on eligible patients with stenosis of at least 70% diameter reduction to evaluate the change in stenosis after the procedure (effectiveness) and the presence of any major adverse events (safety) for up to 30 days after the procedure.

Peripheral Artery Disease

Rex Medical121 participantsStarted Jun 2017

Darien, Connecticut, United States • Jacksonville, Florida, United States • Lauderdale Lakes, Florida, United States +14 more locations

A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies

Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization

Find Trials by Condition in Detroit

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population

Influence of Mucosa Tissue Thickness on Marginal Bone Loss of Implants With Smooth Collars

A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects

A Study of A-101 Topical Solution for the Treatment of Common Warts

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail

Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia

Telehealth Powerful Tools for Caregivers Effectiveness Study

Vectors Post Market: A Study to Assess Pain Relief Using Spinal Cord Stimulation

Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis

A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer

Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)

The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias

Topical Rapamycin to Erase Angiofibromas in TSC

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Sebacia Postmarket Study of Real-World Use

TRANSLINK: Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves